Nature-Based Exercise for Major Depressive Disorder
Key facts
- Who runs it
- University of the Basque Country (UPV/EHU)
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 206 people, planned
- Starts
- 1 Jan 2027
- Expected to end
- Dec 2029
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Nature-Based Combined Exercise Program
- Indoor Combined Exercise Program
- Usual Mental Healthcare and Occupational Activities
- Record updated
- 12 November 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (19)Hide the full registry criteria
Who can take part
- Age between 18 and 75 years, inclusive
- Diagnosis of major depressive disorder (MDD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), confirmed by a psychiatrist from the research team
- At least moderate depressive symptom severity, defined as a baseline score of 20 or higher on the Montgomery-Åsberg Depression Rating Scale (MADRS)
- Sufficient physical capacity to participate safely in a supervised exercise program, as determined by clinical assessment
- Availability and willingness to participate in a 12-week exercise intervention involving two supervised sessions per week if allocated to an exercise group
- Access to a mobile phone to facilitate communication with the research team
- Sufficient understanding and spoken proficiency in Spanish to complete the study assessments and questionnaires
- Ability to understand the study procedures and provide written informed consent; Participants receiving psychopharmacological treatment are eligible. Strict stability of psychopharmacological treatment before enrollment is not required, as the trial is conducted under conditions reflecting routine clinical practice
Who cannot take part
- Diagnosis of a psychotic disorder, including schizophrenia or other schizophrenia-spectrum or psychotic disorders
- High or imminent suicide risk, as determined through clinical assessment by the psychiatric team
- Active substance use disorder, other than nicotine use disorder, requiring specific treatment
- Severe psychiatric comorbidity constituting the primary focus of treatment, such as active bipolar disorder or severely decompensated personality disorder
- Significant cognitive impairment, defined as a score below 26 on the Montreal Cognitive Assessment (MoCA)
- Severe or unstable medical conditions that may interfere with study participation or the safe performance of physical exercise
- Medical contraindications to moderate- or vigorous-intensity physical exercise, including relevant cardiovascular, respiratory, musculoskeletal, or metabolic limitations
- Regular participation in structured moderate- or vigorous-intensity exercise programs totaling 150 minutes or more per week during the three months preceding enrollment
- Planned absence from the participant's usual place of residence for more than two weeks during the intervention period
- Current pregnancy or plans to become pregnant during the intervention period
- Unwillingness to participate in the study or to accept random assignment to any of the three study groups
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Major depressive disorder
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Major depressive disorder (MDD) is a common and disabling mental health condition that can substantially affect emotional well-being, daily functioning, physical health, and quality of life. Although medication and psychotherapy are established treatments, many people continue to experience depressive symptoms and related health problems. Supervised physical exercise has emerged as a promising complementary treatment for depression. However, it remains unclear whether exercising in natural environments provides additional benefits compared with performing a similar exercise program indoors.
Read full original descriptionShow less
The NEST study (Nature-Based Exercise for Major Depressive Disorder) aims to investigate the effects of supervised physical exercise performed in natural versus indoor environments on depressive symptoms in adults with major depressive disorder. The study will also examine whether these exercise programs improve physical fitness, cardiometabolic health, daily functioning, psychological well-being, and quality of life.
NEST is a randomized, controlled, three-arm clinical trial that plans to enroll 206 adults aged 18 to 75 years with major depressive disorder. Participants will be recruited through mental health services in Álava, Spain. Eligible participants will be randomly assigned to one of three groups:
1. Nature-based exercise group: Participants will complete a supervised exercise program in natural green spaces in Vitoria-Gasteiz. 2. Indoor exercise group: Participants will complete a comparable supervised exercise program in indoor facilities. 3. Usual-care control group: Participants will continue receiving usual mental healthcare, together with general physical activity and healthy lifestyle recommendations and occupational activities.
Both exercise groups will participate in a 12-week program consisting of two supervised sessions per week, lasting approximately 80 minutes each. Sessions will combine aerobic interval exercise and resistance training. Exercise intensity will be individually adjusted and monitored by qualified professionals. The main difference between the two exercise groups will be the environment in which the sessions take place.
All participants will undergo assessments before the intervention and after 12 weeks. The primary outcome will be the change in depressive symptom severity, measured using the Montgomery-Åsberg Depression Rating Scale (MADRS).
Secondary assessments will examine clinical functioning, quality of life, cardiorespiratory fitness, muscle strength, body composition, physical activity, cardiometabolic risk factors, and selected inflammatory and neurotrophic biomarkers. The study will also explore participants' experiences of the exercise programs.
Exercise will be provided as an addition to usual mental healthcare rather than as a replacement for prescribed treatments. The findings may help determine whether natural environments offer additional therapeutic benefits and inform the development of accessible, supervised exercise programs for people living with major depressive disorder.
The 3 groups in the trial
- Nature-Based Exercise GroupTreatment being tested
Participants allocated to this group will complete a 12-week supervised combined exercise program in natural green spaces in Vitoria-Gasteiz, Spain, in addition to continuing their usual mental healthcare. The program will include two approximately 80-minute sessions per week, combining aerobic interval training and resistance exercises. Exercise intensity will be individualized according to baseline fitness assessments and monitored by qualified exercise professionals. Sessions will take place in natural environments, with training progression adapted to participants' physical capacity and clinical condition.
Treatment: Nature-Based Combined Exercise Program
- Indoor Exercise GroupExisting treatment, for comparison
Participants allocated to this group will complete a 12-week supervised combined exercise program in indoor facilities at the Psychiatric Hospital of Álava, Spain, in addition to continuing their usual mental healthcare. The program will include two approximately 80-minute sessions per week, combining aerobic interval training and resistance exercises. Exercise intensity, session structure, and progression will be comparable to those of the nature-based exercise group. The main difference between the two exercise programs will be the environment in which the sessions are performed.
Treatment: Indoor Combined Exercise Program
- Usual-Care Control GroupExisting treatment, for comparison
Participants allocated to the control group will continue receiving their usual mental healthcare, including psychiatric follow-up and prescribed treatments as clinically indicated. They will receive general recommendations concerning physical activity and healthy lifestyle habits and will participate in occupational activities according to the study protocol. They will not receive either of the structured supervised exercise programs being investigated. Participants will complete the same baseline and 12-week outcome assessments as the exercise groups.
Treatment: Usual Mental Healthcare and Occupational Activities
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Nature-Based Exercise for Major Depressive Disorder: The NEST Randomized Clinical Trial
- Criteria questions
- Built from NCT07931443, who can take part
- Record updated
- 12 November 2026